Related Experiment Video
Updated: Dec 23, 2025

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Psychometric evaluation of the pediatric applied cognition scale in pediatric hematology/oncology
Kaitlin A Oswald1, Whitney D Fosco2, Dustin E Sarver3,4
1Department of Psychiatry, University of Michigan , Ann Arbor, MI, USA.
Insights
The Pediatric Applied Cognition (PAC) Short Form shows strong reliability for assessing cognitive concerns in pediatric cancer patients. It correlates with psychosocial issues and academic performance, aiding in early identification of neurocognitive deficits.
Area of Science:
- Pediatric Psychology
- Neuro-oncology
- Psychometrics
Background:
- Pediatric patients with hematology/oncology conditions frequently experience neurocognitive deficits due to disease and treatment.
- Accurate screening tools are essential for identifying these cognitive impairments.
- The Pediatric Applied Cognition (PAC) Short Form assesses attention and memory concerns.
Purpose of the Study:
- To evaluate the psychometric properties of the PAC Short Form in pediatric patients with hematology/oncology conditions.
- To determine the reliability and validity of the PAC Short Form in this specific population.
- To explore the association between PAC scores and psychosocial/academic functioning.
Main Methods:
- The study included 222 pediatric patients undergoing hematology/oncology treatment.
- Participants and their caregivers completed the PAC Short Form and self-report measures.
- Psychometric analyses included internal consistency and correlational analyses.
Main Results:
- The PAC Short Form demonstrated strong internal consistency for both child (α = 0.81-0.89) and parent (α = 0.92-0.95) reports.
- Increased cognitive concerns on the PAC were linked to greater psychosocial issues (anxiety, depression, fatigue) and lower academic grades.
- The Parent PAC provided incremental predictive value for child-reported depression, mobility issues, and academic performance.
Conclusions:
- The PAC Short Form appears to be a reliable tool for identifying general academic and psychosocial concerns in pediatric hematology/oncology patients.
- Findings suggest the PAC can serve as a useful indicator of cognitive and related functional impairments.
- Further research is recommended to validate the PAC against performance-based neurocognitive assessments and academic achievement data.
Abstract:
Pediatric patients with hematology and oncology conditions often experience disease- and treatment-related neurocognitive deficits. Well-validated screening tools are critical for identifying patients experiencing cognitive impairments. The Pediatric Applied Cognition scale (PAC) Short Form, developed by the National Institutes of Health, assesses attention and memory concerns. The current study is the first to examine the psychometrics of the PAC in pediatric patients with hematology/oncology conditions. Pediatric patients (n = 222) and caregivers completed the PAC and self-report measures of psychosocial and academic functioning. Results revealed strong internal consistency for the Child (α = 0.81-0.89) and Parent (α = 0.92-0.95) PAC. More cognitive concerns on the Child/Parent PAC were associated with greater psychosocial concerns (e.g. anxiety, depression, and fatigue) and lower reported school grades. The Parent PAC incrementally predicted child reported symptoms of depression, mobility concerns, and school grades beyond the Child PAC. Overall, the PAC Short Form may be useful as an indicator of general academic and psychosocial concerns. Further research validating the PAC in relation to performance-based neurocognitive outcomes and academic achievement is needed in children treated for hematology/oncology conditions.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020